Picture of Biosenic SA logo

BIOS Biosenic SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Bone Therapeutics Signs Partnership With Implant Therapeutics

Sept 28 (Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * BONE THERAPEUTICS SIGNS RESEARCH PARTNERSHIP WITH IMPLANT
THERAPEUTICS TO ACCESS INDUCED PLURIPOTENT STEM CELLS (IPSC)
    * IPSC TECHNOLOGY ALLOWS FOR DEVELOPMENT OF NEXT-GENERATION
CELL
THERAPY PRODUCTS AS A KEY ADDITION TO BONE THERAPEUTIC'S
EXISTING CELL THERAPY PLATFORM
    * BONE THERAPEUTICS WILL, IN PARALLEL, CONTINUE TO RESEARCH
AND
EVALUATE A NUMBER OF GENES THAT ARE OF INTEREST AS WELL AS
GENETIC MODIFICATION TECHNOLOGIES AND METHODOLOGIES
    * THIS SEPARATE ACTIVITY WILL BE UNDERTAKEN TO ENHANCE
FUNCTIONALITY AND EFFICACY OF MSCS FOR SPECIFIC INDICATIONS

Source text for Eikon:  ID:nGNE51KjMN 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))

Recent news on Biosenic SA

See all news